Propriedade e atividade de insiders de Avanos Medical, Inc. (AVNS): operações de insiders, negociações do Senado e da Câmara dos EUA e ações em circulação. Acompanhe como executivos e políticos negociam a ação.
Preço
| Preço | $24.99 |
| Capitalização | $1.2B |
| Bolsa | NYSE |
| País | US |
Balanço (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caixa e Equivalentes | $113.7M | $219.7M | $384.5M | $205.3M | $111.5M | $118.5M | $127.7M | $87.7M | $107.7M | $89.8M |
| Investimentos de Curto Prazo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Contas a Receber | $188.5M | $203.0M | $150.5M | $163.8M | $167.9M | $131.2M | $167.9M | $142.8M | $132.8M | $103.8M |
| Estoque | $272.5M | $91.1M | $121.4M | $145.9M | $168.9M | $159.3M | $132.3M | $163.2M | $138.8M | $148.0M |
| Ativos Circulantes | $593.5M | $1.16B | $713.6M | $538.5M | $467.2M | $427.6M | $624.1M | $487.0M | $393.4M | $355.4M |
| Imobilizado | $260.8M | $109.9M | $154.1M | $248.5M | $223.6M | $206.7M | $146.1M | $144.0M | $144.8M | $141.0M |
| Ágio | $1.03B | $764.7M | $783.6M | $800.9M | $802.5M | $801.6M | $760.3M | $796.1M | $455.6M | $394.9M |
| Ativos Intangíveis | $169.8M | $148.9M | $168.2M | $184.3M | $157.7M | $141.2M | $234.2M | $239.5M | $112.3M | $117.8M |
| Ativos Totais | $2.07B | $2.20B | $1.83B | $1.80B | $1.67B | $1.60B | $1.79B | $1.69B | $1.15B | $1.07B |
| Contas a Pagar | $160.6M | $171.2M | $169.9M | $83.0M | $67.6M | $56.4M | $67.9M | $56.3M | $54.3M | $55.5M |
| Dívida de Curto Prazo | 0 | $39.8M | 0 | 0 | 0 | $14.7M | $6.2M | $8.6M | $9.4M | $10.2M |
| Passivos Circulantes | $324.4M | $389.8M | $264.3M | $212.5M | $166.3M | $139.2M | $191.0M | $234.6M | $165.9M | $165.2M |
| Dívida de Longo Prazo | $579.0M | $541.1M | $247.7M | $248.1M | $180.0M | $130.0M | $226.3M | $159.4M | $125.3M | $90.3M |
| Passivos Totais | $969.3M | $980.5M | $536.2M | $534.4M | $416.3M | $333.0M | $495.7M | $456.1M | $325.7M | $295.5M |
| Reservas | -$379.2M | -$299.9M | -$242.4M | -$288.3M | -$315.5M | -$303.6M | -$253.1M | -$314.9M | -$707.0M | -$779.9M |
| Patrimônio Líquido | $1.10B | $1.22B | $1.30B | $1.27B | $1.26B | $1.27B | $1.29B | $1.24B | $828.5M | $778.2M |
| Dívida Total | $579.0M | $580.9M | $247.7M | $325.4M | $248.8M | $187.5M | $277.0M | $209.1M | $170.2M | $129.1M |
| Dívida Líquida | $465.3M | $361.2M | -$136.8M | $120.1M | $137.3M | $69.0M | $149.3M | $121.4M | $62.5M | $39.3M |
| Capital de Giro | $269.1M | $770.9M | $449.3M | $326.0M | $300.9M | $288.4M | $433.1M | $252.4M | $227.5M | $190.2M |
Saúde financeira
| Dívida / Patrimônio | 0.18 |
| Liquidez corrente | 2.48 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 0.72 |
Rentabilidade
| Retorno sobre patrimônio | -8.91% |
| Retorno sobre capital investido | -6.03% |
| Retorno sobre ativos | -6.61% |
| Margem bruta | 48.55% |
| Margem operacional | -7.92% |
| Margem líquida | -9.69% |
Empresas relacionadas: AORT · AXGN · CVSA · ITGR · LIVN · VREX
Explorar setor: Healthcare · Medical - Devices
Mais seções de AVNS: Resumo · Financeiros · Avaliação · Estatísticas · Estimativas · Técnico · Notícias · Eventos
Descubra mais: Radar — sinais de ações subvalorizadas · Academia de Investimento — aprenda a analisar ações